BLCO
Bausch + Lomb Corporation · Healthcare · Medical - Instruments & Supplies
Momentum inputs (comparable managers):
holder breadth +30.0% ·
share flow +22.6% ·
net new positions +20.0%
· formula
Broad accumulation: rising shares across more holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q4 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q3 2026 | 1 | 0 | 200 | $3,250 | n/a | n/a |
| Q2 2026 | 46 | +1 | 24.68M | $408.72M | +5 | −4 |
| Q1 2026 | 45 | -1 | 23.90M | $380.01M | +5 | −6 |
| Q4 2025 | 46 | +1 | 23.58M | $402.66M | +2 | −1 |
| Q3 2025 | 13 | -2 | 16.68M | $251.34M | n/a | −2 |
| Q2 2025 | 12 | -2 | 14.01M | $182.32M | +1 | −3 |
| Q1 2025 | 12 | +1 | 9.66M | $140.02M | +2 | −1 |
| Q4 2024 | 11 | +3 | 8.82M | $159.20M | +3 | n/a |
| Q3 2024 | 7 | -1 | 7.17M | $138.23M | +1 | −2 |
| Q2 2024 | 8 | n/a | 5.22M | $75.80M | n/a | n/a |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Icahn Capital ✦ | 3.50M | 0.0% | $63.21M | 0.9% | Held | 3 | SEC ↗ |
| 2 | D. E. Shaw & Co. ✦ | 1.88M | -1.6% | $34.03M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 3 | Arrowstreet Capital ✦ | 1.22M | +51.5% | $22.00M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 4 | Citadel Advisors ✦ | 883.55K | +125.6% | $15.96M | 0.0% | ▲ Add | 3 | SEC ↗ ×2 |
| 5 | T. Rowe Price ✦ | 781.90K | New | $14.12M | 0.0% | New | 1 | SEC ↗ ×2 |
| 6 | Marshall Wace ✦ | 374.47K | -19.2% | $6.76M | 0.0% | ▼ Trim | 3 | SEC ↗ ×3 |
| 7 | GAMCO Investors ✦ | 69.80K | -2.2% | $1.26M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 8 | Millennium Management ✦ | 40.67K | New | $734,572 | 0.0% | New | 1 | SEC ↗ |
| 9 | State Street Global Advisors ✦ (passive) | 27.05K | n/a | $488,523 | 0.0% | n/c | 1 | SEC ↗ |
| 10 | Renaissance Technologies ✦ | 20.60K | New | $372,036 | 0.0% | New | 1 | SEC ↗ |
| 11 | Two Sigma Investments ✦ | 14.50K | -28.9% | $261,870 | 0.0% | ▼ Trim | 2 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| T. Rowe Price | $14.12M | 0.0% |
| Millennium Management | $734,572 | 0.0% |
| Renaissance Technologies | $372,036 | 0.0% |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 95 holders, 37.97M shares, $580.19M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
Officer · 52.90K sh · $887,662
Director · 6.06K sh · $100,458
Director · 12.50K sh · $206,250
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology